Simon Fraser University
Engaging the World

This funding opportunity is part of the Government of Canada's continued rapid response to address the health challenges of the COVID-19 pandemic. The funding will enable a rapid and timely research response to the current phase of the COVID-19 pandemic in Canada and around the globe. This funding opportunity is focused on research associated with the emergence of SARS-CoV-2 variants of concern, specifically to determine and define their biological relevance in order to inform public health and health systems strategies.

The purpose of this funding opportunity is to fund mid-career applied public health researchers in Canada who will undertake applied research programs that tackle pressing public health challenges and who will work with decision makers to help support evidence-informed decisions that improve health and health equity.

The purpose of this funding opportunity is to support teams of researchers, patient/patient association representative/family member/caregiver partners and knowledge users (including but not limited to decision makers, policy makers, clinician scientists, health professionals) to investigate prospectively the indirect socio and economic cost of inherited diseases in Canada.

With this award, CIHR and Coalition for Epidemic Preparedness Innovations (CEPI) are each providing grant funding for a mutually beneficial research project that mid-career researchers will co-develop with CEPI. The co-developed project will align with CEPI’s mission and priority diseases, and fall within one or more research area(s) of this funding opportunity.

The Health Research Training Platform (HRTP) Pilot funding opportunity is intended to support the development of interdisciplinary, inter-jurisdictional, and intersectoral research training platforms that will attract a diverse cadre of high-caliber trainees and ECRs, and equip them with the skills required for academic and non-academic careers. These research training platform grants can be used to build capacity in established or emerging areas, within the scope of the research training areas identified in the funding pools outlined below.

The CIHR HIV/AIDS Community-Based Research (CBR) Program is one of four research funding areas of the CIHR HIV/AIDS Research Initiative. The CIHR HIV/AIDS Research Initiative is responsible for the research components of the major Government of Canada initiative in HIV/AIDS, namely the Federal Initiative to Address HIV/AIDS in Canada (FI).

The purpose of this funding opportunity is to support teams of researchers, patient/patient association representative/family member/caregiver partners and knowledge users (including but not limited to decision makers, policy makers, clinician scientists, health professionals) to investigate prospectively the indirect socio and economic cost of inherited diseases in Canada.

The Team Grants in Diabetes Prevention and Treatment in Indigenous Communities: Resilience and Wellness will support Indigenous-led and community-driven research that aims to reverse the upward trajectory of diabetes and associated co-morbidities (e.g. cardiometabolic disease) among First Nations, Inuit and Métis Peoples and their communities. The objective of this component is to define and integrate models of resilience and wellness into diabetes prevention and treatment approaches among First Nations, Inuit and Métis Peoples.

The goal of the Catalyst Grants: STBBI Research in Canada: Beyond HIV/AIDS and Hepatitis C funding opportunity is to identify Canadian strengths in STBBI research and support innovative research ideas beyond the fields of HIV and hepatitis C. This investment is expected to enable researchers to generate preliminary data, validate methodology or tools, and/or explore novel (high risk) research ideas, which will help enhance the success of subsequent applications to CIHR open and strategic competitions focused on priority areas from the STBBI Action Plan.

CIHR-IG is partnering with approximately 18 international funding organizations in the context of this European Joint Programme on Rare Diseases (EJP RD) call for proposals 2021. CIHR-IG is committed to expanding and improving the diagnosis and treatment of rare diseases by creating the conditions needed to bring together creative, dynamic, interdisciplinary teams of researchers from across Canada and the European Community (EC) to collaborate for better health outcome for the rare disease patient community.

This third and final phase will provide funding for Indigenous-led teams to implement their ideas through research and action-oriented, community-based participatory projects that will improve wellness for Indigenous Peoples from a gendered perspective. Some possible examples of community-based participatory projects might include but are not limited to: projects with a focus on the arts as a means to improving wellness from a gendered lens (e.g., visual, music, dance, theatre, literary or media, including contemporary practice of traditionally-based forms); or participatory programs that focus on and strengthen the relationship between gender, wellness and cultural traditions and activities (e.g., ceremony, land-based activities).

The Health Research Training Platform (HRTP) Pilot funding opportunity is intended to support the development of interdisciplinary, inter-jurisdictional, and intersectoral research training platforms that will attract a diverse cadre of high-caliber trainees and ECRs, and equip them with the skills required for academic and non-academic careers. These research training platform grants can be used to build capacity in established or emerging areas, within the scope of the research training areas identified in the funding pools outlined below.

This third and final phase will provide funding for Indigenous-led teams to implement their ideas through research and action-oriented, community-based participatory projects that will improve wellness for Indigenous Peoples from a gendered perspective. Some possible examples of community-based participatory projects might include but are not limited to: projects with a focus on the arts as a means to improving wellness from a gendered lens (e.g., visual, music, dance, theatre, literary or media, including contemporary practice of traditionally-based forms); or participatory programs that focus on and strengthen the relationship between gender, wellness and cultural traditions and activities (e.g., ceremony, land-based activities).

The goal of the CIHR-ICRH/CAAIF/AZ Canada/AllerGen Emerging Researcher Awards in Allergic Asthma is to enable Canadian allergists, clinical immunologists, MD clinician scientists, and basic scientists working in translational research to pursue academic research in allergic asthma.

This catalyst grant supports research to expand current evidence and understanding of disease prevention that will lead to future intervention studies.

This funding opportunity supports the development and testing of innovative methodologies/designs of innovative clinical trials (iCT) that is integrated with the principles of Strategy for Patient-Oriented Research (SPOR).

Recognizes exceptional contributions in the area of population and public health research.

Recognizes an outstanding contribution to health services and policy research, policy and/or care delivery in Canada.

The Team Grants in Diabetes Prevention and Treatment in Indigenous Communities: Resilience and Wellness will support Indigenous-led and community-driven research that aims to reverse the upward trajectory of diabetes and associated co-morbidities (e.g. cardiometabolic disease) among First Nations, Inuit and Métis Peoples and their communities. The objective of this component is to define and integrate models of resilience and wellness into diabetes prevention and treatment approaches among First Nations, Inuit and Métis Peoples.

Honours excellence in health research and its translation into benefits for Canadians. These prizes, worth $100,000, are awarded every two years (with competitions closing in even-numbered years). These are institutional nominations;

This opportunity is to support the establishment of a multidisciplinary platform with the research expertise to identify best practices for studying sex and age as biological variables in basic science, provide training, and promote these methods and services.

This program supports outstanding new investigators as they develop their careers as independent research scientists or clinician scientists to undertake high-quality cancer research, while in close collaboration and mentorship with established TFRI or CIHR-ICR-funded research teams